Clinical trial

SNIFF - 3-Week Aptar CPS Device

NCT05006599

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2025-05-01

PhasePHASE2

Study timeline

Study start (estimated)2025-05-01Date precision: month

Registry last updated2025-07-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Cognitive Impairmentunresolved

Cognitive Impairmentunresolved

Alzheimer Disease, Early Onsetunresolved

Interventions

Insulin (Humulin® R U-100)DRUG

Aptar Pharma CPS Intranasal Delivery DeviceDEVICE

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05006599 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.